News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
4682
Sources here
23
Companies here
26
Search results Stored financial headlines

Active search

4682 matching headlines

Ticker or company: EGMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

ATI Inc (NYSE: ATI) CEO sells 24,845 shares for tax and estate planning

Kimberly A. Fields, Chair, President, and CEO of ATI Inc. (NYSE: ATI), sold 24,845 shares of common stock on August 17, 2026. These sales were executed through a Rule 10b5-1 trading plan established on February 5, 2026, specifically for personal tax and estate planning. …

ATI main company
Sharemaestro market context Trend signal active 52 weeks +210.0% · Next-week setup positive 57.3% ATI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aegon stock holds steady as legal merger and asset management strategy shape outlook

Aegon stock is trading steadily despite significant strategic developments, including the legal merger of its Dutch life insurance operations and its asset management arm's focus on shorter-dated corporate credit in a high-yield bond environment. Investors are observing the impact of these changes on earnings …

AEG main company
Sharemaestro market context Trend signal active 52 weeks +25.7% · Next-week setup positive 60.5% AEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trump Opens Door to Hyperliquid as US Pulls Crypto Trade Onshore

(Bloomberg) -- President Donald Trump said US regulators are working to bring Hyperliquid, a fast-growing crypto platform, into the country, offering one of the clearest signals yet that the White House wants to pull a major piece of the industry's offshore market infrastructure onshore. …

PURR main company
Sharemaestro market context Trend signal active 37 weeks +81.5% · Next-week setup negative 41.4% PURR stored weekly price path from 5 Dec 2025 to 14 Aug 2026

Hyperliquid Strategies Inc Announces Webcast to Discuss Results for the Fiscal Year Ended June 30, 2026

Hyperliquid Strategies Inc (HSI) announced it will host a webcast on August 27, 2026, at 8:00 a.m. ET to discuss its financial and operational results for the fiscal year ended June 30, 2026. The webcast will include remarks from CEO David Schamis and CFO …

PURR main company
Sharemaestro market context Trend signal active 37 weeks +81.5% · Next-week setup negative 41.4% PURR stored weekly price path from 5 Dec 2025 to 14 Aug 2026

Regeneron Announces Investor Conference Presentations

Regeneron Pharmaceuticals, Inc. TARRYTOWN, N.Y., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ET on Wednesday, September 9, 2026 Morgan Stanley 24th Annual Global Healthcare Conference at …

REGN main company REGN34 main company REGN main company RGO main company REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Allegion (NYSE: ALLE) exec exercises options, then sells 549 shares

Allegion plc (ALLE) officer David S. Ilardi, President-Amer & SVP-Allegion, exercised stock options for 549 Ordinary Shares at $71.835 per share on August 18, 2026. On the same day, he sold all 549 newly acquired shares in an open-market transaction at $161.09 per share. …

ALLE main company
Sharemaestro market context Price above Trend Line 52 weeks -3.0% ALLE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Hyperliquid Strategies (PURR) Stock Is Up Today

Hyperliquid Strategies (PURR) stock rose 8.9% today, likely due to renewed buying interest in Hyperliquid-linked equities rather than a specific company announcement. The company's high sensitivity to the underlying Hyperliquid ecosystem, driven by its large holding of HYPE tokens, suggests a sentiment-driven rally. Large …

PURR main company
Sharemaestro market context Trend signal active 37 weeks +81.5% · Next-week setup negative 41.4% PURR stored weekly price path from 5 Dec 2025 to 14 Aug 2026

Omega Flex Stock Down 6% as Q2 Earnings Decline Year Over Year

Shares of Omega Flex, Inc. OFLX have declined 5.6% since the company reported its earnings for the quarter ended June 30, 2026, compared with a 0.4% decline in the S&P 500 index over the same period. Over the past month, Omega Flex shares have …

OFLX main company
Sharemaestro market context Price below Trend Line 52 weeks -18.4% OFLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

US FDA approves Regeneron's rare bone disorder drug

The U.S. FDA has approved Regeneron's experimental drug, garetosmab (branded as Pasatru), for the rare genetic disorder fibrodysplasia ossificans progressiva (FOP). The drug significantly reduced abnormal bone formation in soft tissues, with trials showing a 90-94% reduction in new bone abnormalities. This approval addresses …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NORWEGIAN CRUISE LINE® UNVEILS NEW WAYS TO UNWIND, DINE AND VACATION ABOARD THE SOON-TO-DEBUT NORWEGIAN AURA

Norwegian Cruise Line has unveiled new wellness and dining experiences for its upcoming ship, Norwegian Aura. The ship will feature the industry's most expansive Thermal Spa with 15 wellness experiences, NCL's first specialty Indian restaurant called Tamara, and The Panorama Room, an immersive complimentary …

NCLHN main company N1CL34 main company NCLH main company NCLH main company
Sharemaestro market context Price below Trend Line 52 weeks -30.3% · Next-week setup positive 56.9% NCLHN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regeneron Pharmaceuticals Announces FDA Approval of Pasatru for Adults With Fibrodysplasia Ossificans Progressiva

Regeneron Pharmaceuticals has received FDA approval for Pasatru™ (garetosmab-grts) to treat adults with fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterized by debilitating bone growth. The approval is based on Phase 3 OPTIMA trial results showing a 90-94% reduction in new heterotopic ossification …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regeneron wins FDA nod for rare bone disorder therapy

[FDA Headquarters] * The U.S. Food and Drug Administration on Wednesday approved Pasatru, a treatment developed by Regeneron (REGN [https://seekingalpha.com/symbol/REGN]) for adults with an ultra-rare bone growth disorder known as fibrodysplasia ossificans progressiva. * Earlier this year, the regulator granted priority review for the …

REGN main company REGN34 main company REGN main company RGO main company REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regeneron rare bone disorder therapy approved (REGN:NASDAQ)

The U.S. Food and Drug Administration (FDA) has approved Regeneron's drug, Pasatru, for treating fibrodysplasia ossificans progressiva (FOP), an ultra-rare bone growth disorder in adults. This approval follows the regulator's earlier decision to grant priority review for the company's Biologics License Application. This development …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ATI Slides 3.9% as Investors May Be Locking In Gains After Recent Rally

ATI Inc. (ATI) stock declined by 3.9% today, likely due to profit-taking by investors after a recent rally. The company had reported strong Q2 2026 results and raised its full-year outlook, with no new negative company-specific news identified. Insider trading shows 22 sales and …

ATI main company
Sharemaestro market context Trend signal active 52 weeks +210.0% · Next-week setup positive 57.3% ATI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pegasystems (PEGA) Stock Trades Up, Here Is Why

Shares of Pegasystems (PEGA) rose 3.7% after the company announced a partnership with Gryphon and introduced new AI tools for marketing compliance and transparency. This comes after a significant drop in its stock price due to a slowdown in contract growth and weaker forward-looking …

PEGA main company
Sharemaestro market context Price below Trend Line 52 weeks -38.8% PEGA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Leggett & Platt Inc. stock outperforms competitors on strong trading day

Leggett & Platt Inc. (LEG) shares increased by 3.42% to $9.68 on Wednesday, outperforming the broader market which also saw gains in the S&P 500 and Dow Jones Industrial Average. This rise ended a three-day losing streak for the company's stock.

LEG main company
Sharemaestro market context Price below Trend Line 52 weeks +1.9% LEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Norwegian Cruise Line Holdings Ltd. stock underperforms Wednesday when compared to competitors

Norwegian Cruise Line Holdings Ltd. (NCLH) stock fell by 1.53% on Wednesday, closing at $17.34. This underperformance occurred despite a positive trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. The stock experienced …

NCLH main company
Sharemaestro market context Price below Trend Line 52 weeks -24.1% · Next-week setup positive 59.9% NCLH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Donegal Mutual Insurance acquires $371,194 of Donegal Group common shares

Donegal Mutual Insurance, a 10% owner of Donegal Group, purchased 20,000 Class A common shares for approximately $371,194 through open-market transactions. This acquisition increased their Class A stake to 14.17 million shares, while their Class B holdings remained at 4.75 million shares. The transaction …

DGICB main company
Sharemaestro market context Trend signal active 52 weeks +67.2% · Next-week setup negative 44.8% DGICB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

REGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on behalf of investors who purchased securities between August 1, 2025, and May 15, 2026. The lawsuit alleges that Regeneron gave an overly positive view of its Phase …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Entegris (ENTG) CEO uses stock to cover tax bill on RSUs

Entegris (ENTG) President & CEO David Reeder had 5,386 shares of common stock withheld at $150.27 per share to cover tax obligations arising from the settlement of restricted stock units on August 18, 2026. This transaction, categorized as a Code F disposition, is not …

ENTG main company
Sharemaestro market context Trend signal active 52 weeks +84.8% ENTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EG Maintained by Everest Group -- Price Target Raised to $385

TD Cowen analyst Andrew Kligerman maintained a 'Hold' rating for Everest Group Ltd (EG) and raised its price target from $365.00 to $385.00. The stock is considered approximately 0.4% overvalued according to GuruFocus's GF Value, despite having a strong GF Score of 75/100, indicating …

EG main company
Sharemaestro market context Trend signal active 52 weeks +10.2% EG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NCLH's 8.9% Q3 Net Yield Drop Raises the Stakes for Its 2027 Reset

Norwegian Cruise Line Holdings Ltd. (NCLH) faces a significant challenge with an expected 8.9% drop in constant-currency net yield for Q3, and a 5% decline projected for 2026. This puts immense pressure on the company's commercial reset strategy, which aims to rebuild demand and …

NCLH main company NCLH main company
Sharemaestro market context Price below Trend Line 52 weeks -24.1% · Next-week setup positive 59.9% NCLH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is NCLH Cheap Enough to Buy Despite Its Earnings and Leverage Risks?

Norwegian Cruise Line Holdings Ltd. NCLH trades at a steep sales-multiple discount, but the lower valuation arrives as earnings estimates fall and leverage stays high. The key question is whether that discount already compensates investors for the depth and duration of the 2026 commercial …

NCLH main company NCLH main company
Sharemaestro market context Price below Trend Line 52 weeks -24.1% · Next-week setup positive 59.9% NCLH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q2 2026 Entegris Inc Earnings Call Transcript

This article provides the transcript of Entegris Inc.'s Q2 2026 earnings call, detailing key financial highlights and strategic developments. The company exceeded guidance with 11% revenue growth, strong free cash flow, and debt reduction. It also covers strategic shifts, such as exiting the life …

ENTG main company
Sharemaestro market context Trend signal active 52 weeks +84.8% ENTG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hyperliquid Strategies (PURR) Climbs As Crypto Rules Evolve

Hyperliquid Strategies Inc (PURR) stock has climbed by 12.85% following news related to SEC crypto rulemaking, even though the company is only mentioned in metadata rather than being the central focus. Despite the lack of direct company-specific news, PURR's chart shows a strong, controlled …

PURR main company
Sharemaestro market context Trend signal active 37 weeks +81.5% · Next-week setup negative 41.4% PURR stored weekly price path from 5 Dec 2025 to 14 Aug 2026

Hyperliquid Strategies PURR Gains Momentum As Crypto Rules Loom

Hyperliquid Strategies Inc. (NASDAQ: PURR) is experiencing a significant surge, with its stock trading up by 12.85% due to investor optimism surrounding its breakthrough AI trading platform. Despite a high price-to-sales ratio, the company exhibits strong financial health, including substantial revenue, net income, and …

PURR main company
Sharemaestro market context Trend signal active 37 weeks +81.5% · Next-week setup negative 41.4% PURR stored weekly price path from 5 Dec 2025 to 14 Aug 2026

Q2 Rundown: Power Integrations (NASDAQ:POWI) Vs Other Analog Semiconductors Stocks

The article provides a Q2 earnings rundown for Power Integrations (NASDAQ:POWI) and compares its performance to other analog semiconductor stocks. It highlights strong Q2 results across the analog semiconductor industry, with Power Integrations exceeding revenue and EPS expectations but seeing a stock dip. The …

POWI main company
Sharemaestro market context Trend signal active 52 weeks +34.7% · Next-week setup negative 39.1% POWI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pegasystems (PEGA) grants director 7,947 fully vested options at $32.32

Pegasystems (PEGA) director Sharon T. Rowlands was granted 3,868 shares of unrestricted common stock and 7,947 fully vested non-statutory stock options with an exercise price of $32.32 per share, expiring in 2036. These awards were compensation for her annual director service. Following these transactions, …

PEGA main company
Sharemaestro market context Price below Trend Line 52 weeks -38.8% PEGA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sol Strategies Inc. Revenue Breakdown – CSE:HODL

Sol Strategies Inc. (CSE: HODL) generated 14.56 million CAD in revenue last year, primarily from its Cryptocurrencies and Blockchain Technology segment. This marks an increase from 9.53 million CAD in the previous year. Canada was the sole contributor to this revenue, accounting for the …

STKE main company
Sharemaestro market context Price below Trend Line 52 weeks -85.0% · Next-week setup negative 42.5% STKE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context